중국 면역 분석 시약 및 장치 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2032년까지의 예측

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF CHINA IMMUNOASSAY REAGENTS AND DEVICE MARKET

1.4 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.8 DBMR MARKET POSITION GRID

2.9 VENDOR SHARE ANALYSIS

2.1 MARKET END USER COVERAGE GRID

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 PREMIUM INSIGHTS

5.1 PESTAL ANALYSIS

5.2 PORTER'S FIVE FORCES ANALYSIS

5.3 TECHNOLOGICAL ADVANCEMENTS IN THE TECHNOLOGICAL ADVANCEMENTS IN THE GLOBAL NATURAL TERPENE MARKET

5.4 MICRO AND MACRO ECONOMIC FACTORS

5.5 PENETRATION AND GROWTH PROSPECT MAPPING

5.6 KEY PRICING STRATEGIES

5.7 INTELLECTUAL PROPERTY (IP) PORTFOLIO ANALYSIS

5.7.1 PATENT QUALITY AND STRENGTH

5.7.2 AND COLLABORATIONS

5.8 COST STRUCTURE BREAKDOWN

5.8.1 IMMUNOASSAY REAGENTS

5.8.2 IMMUNOASSAY DEVICES (ANALYZERS):

5.9 REGULATORY COMPLIANCE

5.9.1 REGULATORY AUTHORITIES

5.9.2 REGULATORY CLASSIFICATIONS

5.9.2.1 CLASS I (LOW RISK)

5.9.2.2 CLASS II (MODERATE RISK)

5.9.2.3 CLASS III (HIGH RISK)

5.9.3 REGULATORY SUBMISSIONS

5.9.4 INTERNATIONAL HARMONIZATION

5.9.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS

5.9.6 REGULATORY CHALLENGES AND STRATEGIES

5.1 OPPORTUNITY MAP ANALYSIS

5.11 VALUE CHAIN ANALYSIS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES

6.1.2 RISING HEALTHCARE INVESTMENTS IN DIAGNOSTIC TECHNOLOGIES

6.1.3 GROWING DEMAND FOR PERSONALIZED MEDICINE AND TREATMENTS

6.1.4 TECHNOLOGICAL ADVANCEMENTS IN IMMUNOASSAY REAGENTS AND DEVICES

6.2 RESTRAINTS

6.2.1 FRAGMENTED MARKET WITH INTENSE LOW-COST COMPETITION CAUSING PRICING PRESSURE

6.2.2 STRINGENT REGULATORY APPROVAL PROCESSES FOR NEW PRODUCTS

6.3 OPPORTUNITIES

6.3.1 GROWTH IN RESEARCH AND DEVELOPMENT OF IMMUNOASSAYS

6.3.2 EXPANSION OF POINT-OF-CARE IMMUNOASSAY TESTING

6.3.3 INDUSTRY COLLABORATIONS ADVANCING IMMUNOASSAY CAPABILITIES

6.4 CHALLENGES

6.4.1 HIGH COST OF ADVANCED IMMUNOASSAY SYSTEMS AND IMPLEMENTATION

6.4.2 SHORTAGE OF SKILLED WORKFORCE AND TECHNICAL EXPERTISE

7 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT TYPE

7.1 OVERVIEW

7.2 IMMUNOASSAY REAGENTS & KITS

7.2.1 CHEMILUMINESCENCE IMMUNOASSAYS KITS AND REAGENTS

7.2.2 ELISA KITS AND REAGENTS

7.2.3 RAPID TEST KITS AND REAGENTS

7.2.4 IMMUNOHISTOCHEMISTRY ASSAYS KITS AND REAGENTS

7.2.5 BEAD-BASED IMMUNOASSAYS KITS AND REAGENTS

7.2.6 WESTERN BLOT KITS AND REAGENTS

7.2.7 ELISPOT KITS AND REAGENTS

7.2.8 RADIOIMMUNOASSAY KITS AND REAGENTS

7.2.9 MICROARRAY IMMUNOASSAYS KITS AND REAGENTS

7.2.10 MULTIPLEX MICROARRAY ASSAYS KITS AND REAGENTS

7.2.11 OTHER IMMUNOASSAY KITS AND REAGENTS

7.3 IMMUNOASSAY DEVICES

7.3.1 ANALYZERS

7.3.1.1 AUTOMATIC ANALYZERS

7.3.1.1.1 CLOSED-ENDED SYSTEMS

7.3.1.1.1.1 MODULAR

7.3.1.1.1.2 FLOOR-STANDING

7.3.1.1.1.3 BENCH-TOP

7.3.1.1.1.4 OTHERS

7.3.1.1.2 OPEN-ENDED SYSTEMS

7.3.1.1.2.1 BENCH-TOP

7.3.1.1.2.2 FLOOR-STANDING

7.3.1.1.2.3 MODULAR

7.3.1.1.2.4 OTHERS

7.3.1.2 SEMI-AUTOMATIC ANALYZERS

7.3.1.2.1 BENCH-TOP

7.3.1.2.2 FLOOR-STANDING

7.3.1.2.3 MODULAR

7.3.1.2.4 OTHERS

7.3.1.1 RENTAL PURCHASE

7.3.1.2 OUTRIGHT PURCHASE

7.3.1.1 BENCH-TOP

7.3.1.2 FLOOR-STANDING

7.3.1.3 MODULAR

7.3.1.4 OTHERS

7.3.2 ACCESSORIES AND CONSUMABLES

7.3.2.1 THERMAL PRINTER

7.3.2.2 BARCODE SCANNER

7.3.2.3 OTHERS

7.3.3 POCT DEVICES

7.3.3.1 BENCH-TOP

7.3.3.2 HANDHELD

8 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM

8.1 OVERVIEW

8.2 CHEMILUMINESCENCE IMMUNOASSAYS (CLIA)

8.3 ENZYME IMMUNOASSAY (EIA/ELISA)

8.3.1 ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA)

8.3.1.1 THIRD-GENERATION ELISA

8.3.1.2 FOURTH-GENERATION ELISA

8.3.1.3 SECOND-GENERATION ELISA

8.3.1.4 FIRST-GENERATION ELISA

8.3.2 ENZYME LINKED FLUORESCENT IMMUNOASSAY (ELFA)

8.4 FLUORESCENCE IMMUNOASSAYS (FIA)

8.5 CHROMATOGRAPHIC IMMUNOASSAYS

8.6 IMMUNOHISTOCHEMISTRY

8.7 RADIOIMMUNOASSAYS (RIA)

8.8 TURBIDIMETRIC IMMUNOASSAYS

8.9 MICROARRAY IMMUNOASSAYS

8.1 COUNTING IMMUNOASSAYS

8.11 OTHERS

9 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE

9.1 OVERVIEW

9.2 LABORATORY BASED

9.3 POINT OF CARE

10 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE

10.1 OVERVIEW

10.2 BLOOD

10.3 URINE

10.4 SALIVA

10.5 OTHERS

11 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION

11.1 OVERVIEW

11.2 INFECTIOUS DISEASES

11.2.1 IMMUNOASSAY REAGENTS & KITS

11.2.2 IMMUNOASSAY DEVICES

11.3 CANCER BIOMARKERS

11.3.1 CARCINO EMBRYONIC ANTIGEN (CEA)

11.3.1.1 IMMUNOASSAY REAGENTS & KITS

11.3.1.2 IMMUNOASSAY DEVICES

11.3.2 ALPHA-FETOPROTEIN (AFP)

11.3.2.1 IMMUNOASSAY REAGENTS & KITS

11.3.2.2 IMMUNOASSAY DEVICES

11.3.3 CARBOHYDRATE ANTIGEN 19-9 (CA 19-9)

11.3.3.1 IMMUNOASSAY REAGENTS & KITS

11.3.3.2 IMMUNOASSAY DEVICES

11.3.4 CARBOHYDRATE ANTIGEN 125 (CA 125)

11.3.4.1 IMMUNOASSAY REAGENTS & KITS

11.3.4.2 IMMUNOASSAY DEVICES

11.3.5 OTHERS

11.3.5.1 IMMUNOASSAY REAGENTS & KITS

11.3.5.2 IMMUNOASSAY DEVICES

11.4 ENDOCRINOLOGY

11.4.1 IMMUNOASSAY REAGENTS & KITS

11.4.2 IMMUNOASSAY DEVICES

11.5 BONE AND MINERAL DISORDERS

11.5.1 IMMUNOASSAY REAGENTS & KITS

11.5.2 IMMUNOASSAY DEVICES

11.6 CARDIOLOGY

11.6.1 IMMUNOASSAY REAGENTS & KITS

11.6.2 IMMUNOASSAY DEVICES

11.7 HEMATOLOGY AND BLOOD SCREENING

11.7.1 IMMUNOASSAY REAGENTS & KITS

11.7.2 IMMUNOASSAY DEVICES

11.8 AUTOIMMUNE DISORDERS

11.8.1 IMMUNOASSAY REAGENTS & KITS

11.8.2 IMMUNOASSAY DEVICES

11.9 TOXICOLOGY

11.9.1 IMMUNOASSAY REAGENTS & KITS

11.9.2 IMMUNOASSAY DEVICES

11.1 NEONATAL SCREENING

11.10.1 IMMUNOASSAY REAGENTS & KITS

11.10.2 IMMUNOASSAY DEVICES

11.11 ALLERGY DIAGNOSTICS

11.11.1 IMMUNOASSAY REAGENTS & KITS

11.11.2 IMMUNOASSAY DEVICES

11.12 GASTROLOGY

11.12.1 IMMUNOASSAY REAGENTS & KITS

11.12.2 IMMUNOASSAY DEVICES

11.13 OTHERS

11.13.1 IMMUNOASSAY REAGENTS & KITS

11.13.2 IMMUNOASSAY DEVICES

12 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER

12.1 OVERVIEW

12.2 HOSPITALS

12.2.1 PUBLIC

12.2.2 PRIVATE

12.2.3 TIER 3

12.2.4 TIER 2

12.2.5 TIER 1

12.3 CLINICAL LABORATORIES

12.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES

12.5 BLOOD BANKS

12.6 RESEARCH AND ACADEMIC LABORATORIES

12.7 AMBULATORY CARE CENTERS

12.8 NURSING HOMES

12.9 HOME HEALTHCARE AGENCIES

12.1 OTHERS

13 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET: COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: CHINA

14 SWOT ANALYSIS

15 COMPANY PROFILES

15.1 F. HOFFMANN-LA ROCHE LTD

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 PRODUCT PORTFOLIO

15.1.4 RECENT DEVELOPMENT/NEWS

15.2 SIEMENS

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 PRODUCT PORTFOLIO

15.2.4 RECENT DEVELOPMENT

15.3 ABBOTT

15.3.1 COMPANY SNAPSHOT

15.3.2 REVENUE ANALYSIS

15.3.3 PRODUCT PORTFOLIO

15.3.4 RECENT DEVELOPMENT/NEWS

15.4 THERMO FISHER SCIENTIFIC INC.

15.4.1 COMPANY SNAPSHOT

15.4.2 REVENUE ANALYSIS

15.4.3 PRODUCT PORTFOLIO

15.4.4 RECENT DEVELOPMENT

15.5 QUIDELORTHO CORPORATION

15.5.1 COMPANY SNAPSHOT

15.5.2 REVENUE ANALYSIS

15.5.3 PRODUCT PORTFOLIO

15.5.4 RECENT DEVELOPMENT/NEWS

15.6 AGILENT TECHNOLOGIES, INC

15.6.1 COMPANY SNAPSHOT

15.6.2 REVENUE ANALYSIS

15.6.3 PRODUCT PORTFOLIO

15.6.4 RECENT DEVELOPMENT

15.7 BD

15.7.1 COMPANY SNAPSHOT

15.7.2 REVENUE ANALYSIS

15.7.3 PRODUCT PORTFOLIO

15.7.4 RECENT DEVELOPMENT/NEWS

15.8 BIO RAD LABORATORIES INC

15.8.1 COMPANY SNAPSHOT

15.8.2 REVENUE ANALYSIS

15.8.3 PRODUCT PORTFOLIO

15.8.4 RECENT DEVELOPMENT

15.9 BIO-TECHNE

15.9.1 COMPANY SNAPSHOT

15.9.2 REVENUE ANALYSIS

15.9.3 PRODUCT PORTFOLIO

15.9.4 RECENT DEVELOPMENT

15.1 BIOMERIEUX

15.10.1 COMPANY SNAPSHOT

15.10.2 REVENUE ANALYSIS

15.10.3 PRODUCT PORTFOLIO

15.10.4 RECENT DEVELOPMENT

15.11 DANAHER CORPORATION

15.11.1 COMPANY SNAPSHOT

15.11.2 REVENUE ANALYSIS

15.11.3 PRODUCT PORTFOLIO

15.11.4 RECENT DEVELOPMENT

15.12 DIASORIN

15.12.1 COMPANY SNAPSHOT

15.12.2 REVENUE ANALYSIS

15.12.3 PRODUCT PORTFOLIO

15.12.4 RECENT DEVELOPMENT/NEWS

15.13 HIPRO BIOTECHNOLOGY CO.LTD.

15.13.1 COMPANY SNAPSHOT

15.13.2 PRODUCT PORTFOLIO

15.13.3 RECENT DEVELOPMENT

15.14 QIAGEN

15.14.1 COMPANY SNAPSHOT

15.14.2 REVENUE ANALYSIS

15.14.3 PRODUCT PORTFOLIO

15.14.4 RECENT DEVELOPMENT

15.15 REVVITY

15.15.1 COMPANY SNAPSHOT

15.15.2 REVENUE ANALYSIS

15.15.3 PRODUCT PORTFOLIO

15.15.4 RECENT DEVELOPMENT

15.16 SD BIOSENSOR, INC.

15.16.1 COMPANY SNAPSHOT

15.16.2 REVENUE ANALYSIS

15.16.3 PRODUCT PORTFOLIO

15.16.4 RECENT DEVELOPMENT

15.17 SYSMEX CORPORATION

15.17.1 COMPANY SNAPSHOT

15.17.2 REVENUE ANALYSIS

15.17.3 PRODUCT PORTFOLIO

15.17.4 RECENT DEVELOPMENT

15.18 TOSOH BIOSCIENCE, INC

15.18.1 COMPANY SNAPSHOT

15.18.2 REVENUE ANALYSIS

15.18.3 PRODUCT PORTFOLIO

15.18.4 RECENT DEVELOPMENT

16 QUESTIONNAIRE

17 RELATED REPORTS